Financial results - ORL ENDOCLINIC SRL

Financial Summary - Orl Endoclinic Srl
Unique identification code: 27589928
Registration number: J22/1429/2010
Nace: 8622
Sales - Ron
286.367
Net Profit - Ron
161.126
Employees
3
Open Account
Company Orl Endoclinic Srl with Fiscal Code 27589928 recorded a turnover of 2024 of 286.367, with a net profit of 161.126 and having an average number of employees of 3. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Orl Endoclinic Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 73.558 74.710 102.897 115.321 131.434 108.285 163.212 243.806 299.461 286.367
Total Income - EUR 73.726 75.823 111.923 115.486 134.271 111.440 174.443 249.664 301.507 293.562
Total Expenses - EUR 66.011 45.389 57.754 56.074 79.347 79.053 90.297 100.905 109.761 123.810
Gross Profit/Loss - EUR 7.715 30.435 54.169 59.412 54.924 32.387 84.146 148.759 191.746 169.752
Net Profit/Loss - EUR 5.759 28.918 52.260 58.259 53.610 31.388 82.555 146.466 189.257 161.126
Employees 2 1 1 1 2 2 2 2 2 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -3.8%, from 299.461 euro in the year 2023, to 286.367 euro in 2024. The Net Profit decreased by -27.073 euro, from 189.257 euro in 2023, to 161.126 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Orl Endoclinic Srl

Rating financiar

Financial Rating -
ORL ENDOCLINIC SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Orl Endoclinic Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Orl Endoclinic Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Orl Endoclinic Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Orl Endoclinic Srl - CUI 27589928

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 28.004 19.327 42.376 33.942 45.947 87.323 57.949 49.474 52.057 72.623
Current Assets 25.181 25.704 43.155 52.375 60.463 57.899 74.936 137.945 159.144 119.981
Inventories 0 0 0 0 0 30 0 0 0 0
Receivables 14.850 2.302 2.015 13.250 3.298 2.823 10.866 106.923 153.503 92.576
Cash 10.331 23.402 41.140 39.125 57.165 55.046 64.071 31.022 5.641 17.353
Shareholders Funds 26.616 28.971 52.312 58.311 54.005 60.867 82.675 146.515 189.306 161.174
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 27.224 16.298 33.385 29.088 51.103 83.707 49.850 41.330 22.740 30.937
Income in Advance 0 0 0 0 1.587 1.193 811 0 0 1.160
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 119.981 euro in 2024 which includes Inventories of 0 euro, Receivables of 92.576 euro and cash availability of 17.353 euro.
The company's Equity was valued at 161.174 euro, while total Liabilities amounted to 30.937 euro. Equity decreased by -27.073 euro, from 189.306 euro in 2023, to 161.174 in 2024. The Debt Ratio was 16.0% in the year 2024.

Risk Reports Prices

Reviews - Orl Endoclinic Srl

Comments - Orl Endoclinic Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.